215 related articles for article (PubMed ID: 11014718)
1. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma.
Wilson AM; Lipworth BJ
Am J Med; 2000 Mar; 108(4):269-75. PubMed ID: 11014718
[TBL] [Abstract][Full Text] [Related]
2. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
3. Dose-response comparison of budesonide dry powder inhalers using adenosine monophosphate bronchial challenge.
Lipworth BJ; Sims EJ; Das SK; Buck H; Paterson M
Ann Allergy Asthma Immunol; 2005 Jun; 94(6):675-81. PubMed ID: 15984601
[TBL] [Abstract][Full Text] [Related]
4. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults.
Aziz I; Wilson AM; Lipworth BJ
Chest; 2000 Oct; 118(4):1049-58. PubMed ID: 11035676
[TBL] [Abstract][Full Text] [Related]
5. The skin vasoconstrictor assay does not correlate significantly to airway or systemic responsiveness to inhaled budesonide in asthmatic patients.
Wilson AM; Coutie WJ; Sims EJ; Lipworth BJ
Eur J Clin Pharmacol; 2003 Feb; 58(10):643-7. PubMed ID: 12610738
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function.
Nielsen LP; Dahl R
Am J Respir Crit Care Med; 2000 Dec; 162(6):2053-7. PubMed ID: 11112113
[TBL] [Abstract][Full Text] [Related]
7. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
Clark DJ; Lipworth BJ
Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464
[TBL] [Abstract][Full Text] [Related]
9. Effects of once daily dosing with inhaled budesonide on airway hyperresponsiveness and airway inflammation following repeated low-dose allergen challenge in atopic asthmatics.
Gauvreau GM; Sulakvelidze I; Watson RM; Inman MD; Rerecich TJ; O'Byrne PM
Clin Exp Allergy; 2000 Sep; 30(9):1235-43. PubMed ID: 10971469
[TBL] [Abstract][Full Text] [Related]
10. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
Prieto L; Gutiérrez V; Morales C
Eur Respir J; 1999 Jun; 13(6):1236-44. PubMed ID: 10445596
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma.
Kharitonov SA; Donnelly LE; Montuschi P; Corradi M; Collins JV; Barnes PJ
Thorax; 2002 Oct; 57(10):889-96. PubMed ID: 12324677
[TBL] [Abstract][Full Text] [Related]
12. Switching from salmeterol/fluticasone to formoterol/budesonide combinations improves peripheral airway/alveolar inflammation in asthma.
Akamatsu T; Shirai T; Kato M; Yasui H; Hashimoto D; Fujisawa T; Tsuchiya T; Inui N; Suda T; Chida K
Pulm Pharmacol Ther; 2014 Feb; 27(1):52-6. PubMed ID: 23583566
[TBL] [Abstract][Full Text] [Related]
13. Adrenocortical activity with repeated twice daily dosing of fluticasone propionate and budesonide given via a large volume spacer to asthmatic school children.
Lipworth BJ; Clark DJ; McFarlane LC
Thorax; 1997 Aug; 52(8):686-9. PubMed ID: 9337826
[TBL] [Abstract][Full Text] [Related]
14. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
[TBL] [Abstract][Full Text] [Related]
15. Once versus twice daily budesonide metered-dose inhaler in children with mild to moderate asthma: effect on symptoms and bronchial responsiveness.
Mallol J; Aguirre V
Allergol Immunopathol (Madr); 2007; 35(1):25-31. PubMed ID: 17338899
[TBL] [Abstract][Full Text] [Related]
16. The effect of inhaled budesonide on the diurnal variation in airway mechanics, airway responsiveness and serum neutrophil chemotactic activity in Asian patients with predominant nocturnal asthma.
Tan WC; Koh TH; Hay CS; Taylor E
Respirology; 1998 Mar; 3(1):13-20. PubMed ID: 9657654
[TBL] [Abstract][Full Text] [Related]
17. The effects of add-on zafirlukast treatment to budesonide on bronchial hyperresponsiveness and serum levels of eosinophilic cationic protein and total antioxidant capacity in asthmatic patients.
Cakmak G; Demir T; Gemicioglu B; Aydemir A; Serdaroglu E; Donma O
Tohoku J Exp Med; 2004 Dec; 204(4):249-56. PubMed ID: 15572850
[TBL] [Abstract][Full Text] [Related]
18. Maximal airway response in adolescents with long-term asthma remission and persisting airway hypersensitivity: its profile and the effect of inhaled corticosteroids.
Koh YY; Park Y; Kim CK
Chest; 2002 Oct; 122(4):1214-21. PubMed ID: 12377844
[TBL] [Abstract][Full Text] [Related]
19. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment.
van der Molen T; Meyboom-de Jong B; Mulder HH; Postma DS
Am J Respir Crit Care Med; 1998 Jul; 158(1):121-5. PubMed ID: 9655717
[TBL] [Abstract][Full Text] [Related]
20. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma].
Weng JL; Zheng YS; Ma QF
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
